Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis-Reference-Cited by-同舟云学术

Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis

Published:2023-06 Issue: Volume:32 Page:704-720
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Lax Antonio,Soler Fernando,Fernandez del Palacio Maria Josefa,Pascual-Oliver Silvia,Ballester Miriam Ruiz,Fuster Jose Javier,Pascual-Figal Domingo,Asensio-Lopez Maria del Carmen

Funder

España Ministerio de Ciencia e Innovación

Instituto de Salud Carlos III

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference56 articles.

1. Affordability and price increases of new cancer drugs in clinical guidelines, 2007-2016;Hwang;JNCI Cancer Spectr.,2018

2. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC);Zamorano;Eur. Heart J.,2016

3. Cardiotoxicity of anthracyclines;Cardinale;Front. Cardiovasc. Med.,2020

4. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention;Henriksen;Heart,2018

5. Anthracycline cardiotoxicity;Menna;Expert Opin. Drug Saf.,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ST2L promotes VEGFA-mediated angiogenesis in gastric cancer by activating TRAF6/PI3K/Akt/NF-κB pathway via IL-33;2024-07-04

2. Cis-Cardio: A comprehensive analysis platform for cardiovascular-relavant cis-regulation in human and mouse;Molecular Therapy - Nucleic Acids;2023-09